Turning information into outcomes with MedThink Communications
Turning information into outcomes with MedThink Communications cbroadwell Thu, 02/01/2024 - 14:03
Turning information into outcomes with MedThink Communications cbroadwell Thu, 02/01/2024 - 14:03
Who's No. 1? With $25B in sales, Merck's Keytruda looks to be the top-selling drug of 2023 kdunleavy Thu, 02/01/2024 - 13:57
4 Ways to Bring Greater Precision to Oncology Omnichannel Experiences jpiatt Thu, 02/01/2024 - 13:46
Despite Vyvanse's loss of exclusivity, Takeda treads water thanks to launch momentum fkansteiner Thu, 02/01/2024 - 12:46
Merck still in the market for deals in the $1B to $15B range, CEO says kdunleavy Thu, 02/01/2024 - 11:03
Despite Roche's sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says aliu Thu, 02/01/2024 - 10:50
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on fkansteiner Thu, 02/01/2024 - 10:02
In Medicare negotiation process, HHS sends first price offers as industry blasts lack of transparency esagonowsky Thu, 02/01/2024 - 09:39
GSK inks another Zantac settlement ahead of trial in California esagonowsky Thu, 02/01/2024 - 07:59